Market Place
Sourcing Support
Sanofi Initiates €1B Share Buyback Mandate
03 Feb 2026 //
PRESS RELEASE
Sanofi Rare Disease Drug Shows Success And Failure In Phase 3
02 Feb 2026 //
PRESS RELEASE
CHMP Backs Sanofi`s Rezurock for EU Chronic GVHD Approval
31 Jan 2026 //
GLOBENEWSWIRE
Sanofi Shifts From mRNA Flu Vaccine As CEO Shows Confidence
30 Jan 2026 //
BIOSPACE
Amgen Exits $400M Autoimmune Pact After Running Vast Program
30 Jan 2026 //
FIERCE BIOTECH
Sanofi Keeps Mum On Denali Pact After Scrapping Final RIPK1 Drug
29 Jan 2026 //
FIERCE BIOTECH
Sensorion Secures €60M Financing For Genetic Medicine Pipeline
28 Jan 2026 //
BUSINESSWIRE
Pfizer Retains Top Spot In Vaccine Rankings As Sanofi Slides
27 Jan 2026 //
FIERCE PHARMA
Sanofi`s Amlitelimab Confirms Its Potential in Atopic Dermatitis
27 Jan 2026 //
PRESS RELEASE
BrightInsight Secures Multi-Million Investment For Ai Medication
20 Jan 2026 //
GLOBENEWSWIRE
Myqorzo And Redemplo Approved In China
17 Jan 2026 //
PRESS RELEASE
FDA Delays Decision On Lilly`s Obesity Drug Orforglipron
17 Jan 2026 //
REUTERS
Speculation Of Sanofi Takeover Sends Ocular`s Stock Soaring
16 Jan 2026 //
BIOSPACE
Sanofi Discloses Voting Rights And Shares For December 2025
14 Jan 2026 //
GLOBENEWSWIRE
Ahmed Moussa Appointed Country Lead For Sanofi UK & Ireland
14 Jan 2026 //
PHARMIWEB
Zip Launches Transformation Office Led by Ex-Fortune 500 CPOs
13 Jan 2026 //
PHARMIWEB
Recludix Doses First Subjects in Phase 1 STAT6 Inhibitor Study
12 Jan 2026 //
GLOBENEWSWIRE
Cytoreason Expands Sanofi Partnership For AI Drug Discovery
10 Jan 2026 //
PR NEWSWIRE
Diagonal Therapeutics Secures $125M Series B
08 Jan 2026 //
GLOBENEWSWIRE
BrightInsight`s developed Sanofi App Boosts Medication Adherence
07 Jan 2026 //
GLOBENEWSWIRE
Sanofi Invests $30M In Enable Injections For Manufacturing Boost
06 Jan 2026 //
GLOBENEWSWIRE
Earendil Labs Announces Strategic Collaboration with Sanofi
06 Jan 2026 //
PR NEWSWIRE
Sanofi`s Tzield Under Priority Review For Children With Diabetes
05 Jan 2026 //
PRESS RELEASE
Tiziana Reports Annual Safety Data For Intranasal Foralumab
29 Dec 2025 //
GLOBENEWSWIRE
Sanofi to acquire Dynavax, Pushes Ahead on Adult Vaccines
27 Dec 2025 //
PRESS RELEASE
Sanofi Provides Update on Tolebrutinib Regulatory Submission
24 Dec 2025 //
PRESS RELEASE
EU Approves Sanofi`s Wayrli as First BTK Inhibitor for ITP
23 Dec 2025 //
PRESS RELEASE
Dupixent Approved in Japan for Children Aged 6 to 11 Years
23 Dec 2025 //
GLOBENEWSWIRE
Sanofi Strikes U.S. Deal to Cut Drug Costs, Boost Innovation
20 Dec 2025 //
GLOBENEWSWIRE
Sanofi Strikes U.S. Deal to Cut Drug Costs, Boost Innovation
19 Dec 2025 //
GLOBENEWSWIRE
Q4 2025 Aide-Mémoire Now Available
18 Dec 2025 //
PRESS RELEASE
Sanofi`s Efdoralprin Alfa Granted EU Orphan Designation
18 Dec 2025 //
PRESS RELEASE
NMPA Approves Aficamten for Hypertrophic Cardiomyopathy
17 Dec 2025 //
GLOBENEWSWIRE
Recludix Pharma Clears FDA For REX-8756, Oral STAT6 Inhibitor
16 Dec 2025 //
GLOBENEWSWIRE
Market update EUROAPI Strengthens Shareholder Commitment
16 Dec 2025 //
PRESS RELEASE
ADEL Secures $1.04B Sanofi Deal for ADEL-Y01
15 Dec 2025 //
PR NEWSWIRE
Sanofi Updates Tolebrutinib for Primary Progressive MS
15 Dec 2025 //
GLOBENEWSWIRE
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
15 Dec 2025 //
BUSINESSWIRE
Finance Ministry Allows 15 Firms To Import Morphine, Codeine
12 Dec 2025 //
PHARMABIZ
Sanofi’s Qfitlia and Cablivi approved in China
12 Dec 2025 //
PRESS RELEASE
Sanofi, GSK Ink Preclinical Pacts In Hunt For New Antibodies
10 Dec 2025 //
FIERCE BIOTECH
FDA Launches Probe Into Safety Of Approved Anti-RSV Antibodies
10 Dec 2025 //
BIOSPACE
Sanofi Invests In Indupro Therapeutics For Autoimmune Bispecific
10 Dec 2025 //
BUSINESSWIRE
Sanofi`s Blueprint Medicines Showcases Ayvakit Benefits At ASH
05 Dec 2025 //
PR NEWSWIRE
Sanofi completes acquisition of Vicebio
05 Dec 2025 //
PRESS RELEASE
Labgenius Pharma Collaborates With Sanofi On AI Antibody Program
04 Dec 2025 //
PRESS RELEASE
Trial Library Secures $10M Series A For Clinical Trial Access
02 Dec 2025 //
PHARMIWEB
EU Approves Dupixent As First Targeted Drug For Chronic Urticaria
26 Nov 2025 //
PRESS RELEASE
Lifordi Immunotherapeutics Secures Sanofi Backing
18 Nov 2025 //
BUSINESSWIRE
Sanofi`s Teizeild Recommended For EU Approval For Stage 2 T1D
15 Nov 2025 //
PRESS RELEASE
Sanofi Discloses October 2025 Voting Rights & Shares
13 Nov 2025 //
GLOBENEWSWIRE
Drugmakers Push FDA To Extend Support To Existing Facilities
11 Nov 2025 //
BIOSPACE
Sanofi Is `Chasing The Miracles Of Science` In New Campaign
10 Nov 2025 //
FIERCE PHARMA
Dupixent Study Meets Endpoints; sBLA Under FDA Priority Review
07 Nov 2025 //
PRESS RELEASE
Novavax Transfers U.S. Marketing Rights For Nuvaxovid
04 Nov 2025 //
PR NEWSWIRE
Press release: Sanofi successfully prices USD 3B of bond issue
28 Oct 2025 //
PRESS RELEASE
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Sanofi India Appoints Deepak Arora As Managing Director
27 Oct 2025 //
ECONOMICTIMES
Sanofi`s Dupixent Reaches Quarterly Sales Of €4B For First Time
24 Oct 2025 //
FIERCE PHARMA
Press Release: Q3: Continued Sales And Earnings Progress
24 Oct 2025 //
PRESS RELEASE
